Insulin resistance and atherosclerosis: Convergence between metabolic pathways and inflammatory nodes

Biochemical Journal

Volumn 454, Issue 1, 2013, Pages 1-11

  Stöhr, Robert ^a   Federici, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Atherosclerosis; Cardiovascular disease; Diabetes; Inflammation; Macrophage; Signal transduction

Indexed keywords

AMINO ACID; CHEMOTACTIC FACTOR; CHOLESTEROL; FATTY ACID; GLUCOSE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXO;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL POPULATION; CELL RESPIRATION; CHEMOTAXIS; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; GLUCOSE TRANSPORT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ATHEROSCLEROSIS; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; MACROPHAGES; METABOLIC NETWORKS AND PATHWAYS; OBESITY;

EID: 84880890303     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130121     Document Type: Review

References (104)

1. Eckel, R. H., Alberti, K. G., Grundy, S. M. and Zimmet, P. Z. (2010) The metabolic syndrome. Lancet 375, 181-183.
2. International Diabetes Federation (2011) IDF Diabetes Atlas, 5th edn, International Diabetes Federation. Brussels, http://www.idf.org/diabetesatlas.
3. Petersen, K. F. and Shulman, G. I. (2006) Etiology of insulin resistance. Am. J. Med. 119, S10-S16.
4. Zeng, G. and Quon, M. J. (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898.
5. Cardillo, C., Nambi, S. S., Kilcoyne, C. M., Choucair, W. K., Katz, A., Quon, M. J. and Panza, J. A. (1999) Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100, 820-825.
6. Grenett, H. E., Benza, R. L., Fless, G. M., Li, X. N., Davis, G. C. and Booyse, F. M. (1998) Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18, 1803-1809.
7. sRossig, L., Haendeler, J., Hermann, C., Malchow, P., Urbich, C., Zeiher, A. M. and Dimmeler, S. (2000) Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J. Biol. Chem. 275, 25502-25507.
8. Kuboki, K., Jiang, Z. Y., Takahara, N., Ha, S. W., Igarashi, M., Yamauchi, T., Feener, E. P., Herbert, T. P., Rhodes, C. J. and King, G. L. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin. Circulation 101, 676-681.
9. Vicent, D., Ilany, J., Kondo, T., Naruse, K., Fisher, S. J., Kisanuki, Y. Y., Bursell, S., Yanagisawa, M., King, G. L. and Kahn, C. R. (2003) The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 111, 1373-1380.
10. Rask-Madsen, C., Li, Q., Freund, B., Feather, D., Abramov, R., Wu, I. H., Chen, K., Yamamoto-Hiraoka, J., Goldenbogen, J., Sotiropoulos, K. B. et al. (2010) Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 11, 379-389.
11. Rask-Madsen, C., Buonomo, E., Li, Q., Park, K., Clermont, A. C., Yerokun, O., Rekhter, M. and King, G. L. (2012) Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice. Arterioscler. Thromb. Vasc. Biol. 32, 1124-1131.
12. Ross, R. (1995) Cell biology of atherosclerosis. Annu. Rev. Physiol. 57, 791-804.
13. DeFronzo, R. A. (1992) Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview. Diabetologia 35, 389-397.
14. Feener, E. P. and King, G. L. (1997) Vascular dysfunction in diabetes mellitus. Lancet 350 (Suppl. 1), SI9-SI13.
15. Hsueh, W. A., Lyon, C. J. and Quinones, M. J. (2004) Insulin resistance and the endothelium. Am. J. Med. 117, 109-117.
16. Raz, I., Eldor, R., Cernea, S. and Shafrir, E. (2005) Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab. Res. Rev. 21, 3-14.
17. Libby, P., Okamoto, Y., Rocha, V. Z. and Folco, E. (2010) Inflammation in atherosclerosis: Transition from theory to practice. Circ. J. 74, 213-220.
18. Oh, D. Y., Morinaga, H., Talukdar, S., Bae, E. J. and Olefsky, J. M. (2012) Increased macrophage migration into adipose tissue in obese mice. Diabetes 61, 346-354.
19. Olefsky, J. M. and Glass, C. K. (2010) Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246.
20. Odegaard, J. I. and Chawla, A. (2011) Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6, 275-297.
21. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L. and Ferrante, Jr A. W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
22. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A. and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830.
23. Lumeng, C. N., Bodzin, J. L. and Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184.
24. Geissmann, F., Jung, S. and Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
25. Tabas, I., Williams, K. J. and Boren, J. (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116, 1832-1844.
26. Lusis, A. J. (2000) Atherosclerosis. Nature 407, 233-241.
27. Martinez, F. O., Helming, L. and Gordon, S. (2009) Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483.
28. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J. and Wynn, T. A. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-Arginine metabolism. J. Immunol. 167, 6533-6544.
29. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A. W. and Chawla, A. (2007) Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120.
30. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V. et al. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
31. Smith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J. and Miyata, M. (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A. 92, 8264-8268.
32. Maradit-Kremers, H., Nicola, P. J., Crowson, C. S., Ballman, K. V. and Gabriel, S. E. (2005) Cardiovascular death in rheumatoid arthritis: A population-based study. Arthritis Rheum. 52, 722-732.
33. Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P. and Stein, C. M. (2003) Premature coronary-Artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2407-2415.
34. Pello, O. M., Silvestre, C., De Pizzol, M. and Andres, V. (2011) A glimpse on the phenomenon of macrophage polarization during atherosclerosis. Immunobiology 216, 1172-1176.
35. Skalen, K., Gustafsson, M., Rydberg, E. K., Hulten, L. M., Wiklund, O., Innerarity, T. L. and Boren, J. (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417, 750-754.
36. Eriksson, E. E., Xie, X., Werr, J., Thoren, P. and Lindbom, L. (2001) Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J. Exp. Med. 194, 205-218.
37. Yvan-Charvet, L., Ranalletta, M., Wang, N., Han, S., Terasaka, N., Li, R., Welch, C. and Tall, A. R. (2007) Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117, 3900-3908.
38. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695.
39. Mantovani, A., Garlanda, C. and Locati, M. (2009) Macrophage diversity and polarization in atherosclerosis: A question of balance. Arterioscler. Thromb. Vasc. Biol. 29, 1419-1423.
40. Libby, P. and Aikawa, M. (2002) Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8, 1257-1262.
41. van Gils, J. M., Derby, M. C., Fernandes, L. R., Ramkhelawon, B., Ray, T. D., Rayner, K. J., Parathath, S., Distel, E., Feig, J. L., Alvarez-Leite, J. I. et al. (2012) The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat. Immunol. 13, 136-143.
42. Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A. T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A. and Caligiuri, G. (2010) Macrophage plasticity in experimental atherosclerosis. PLoS ONE 5, e8852.
43. Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R. and Pittet, M. J. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-Associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195-205.
44. Kirbis, S., Breskvar, U. D., Sabovic, M., Zupan, I. and Sinkovic, A. (2010) Inflammation markers in patients with coronary artery disease: comparison of intracoronary and systemic levels. Wien Klin. Wochenschr. 122 (Suppl. 2), 31-34.
45. Tsimikas, S. and Miller, Y. I. (2011) Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr. Pharm. Des. 17, 27-37.
46. Feig, J. E., Parathath, S., Rong, J. X., Mick, S. L., Vengrenyuk, Y., Grauer, L., Young, S. G. and Fisher, E. A. (2011) Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123, 989-998.
47. Finn, A. V., Nakano, M., Narula, J., Kolodgie, F. D. and Virmani, R. (2010) Concept of vulnerable/unstable plaque. Arterioscler. Thromb. Vasc. Biol. 30, 1282-1292.
48. Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A. et al. (2011) Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ. Res. 108, 985-995.
49. Thorp, E. and Tabas, I. (2009) Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J. Leukocyte Biol. 86, 1089-1095.
50. Spann, N. J., Garmire, L. X., McDonald, J. G., Myers, D. S., Milne, S. B., Shibata, N., Reichart, D., Fox, J. N., Shaked, I., Heudobler, D. et al. (2012) Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151, 138-152.
51. Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S., Ishihara, A., Kanatani, A., Itadani, H. and Kotani, H. (2003) Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 278, 46654-46660.
52. Bruun, J. M., Lihn, A. S., Pedersen, S. B. and Richelsen, B. (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90, 2282-2289.
53. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L. and Ferrante, Jr A. W. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124.
54. Patsouris, D., Li, P. P., Thapar, D., Chapman, J., Olefsky, J. M. and Neels, J. G. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8, 301-309.
55. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., Karin, M. and Hotamisligil, G. S. (2002) A central role for JNK in obesity and insulin resistance. Nature 420, 333-336.
56. Solinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J. L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M. and Karin, M. (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6, 386-397.
57. Park, K. W., Waki, H., Villanueva, C. J., Monticelli, L. A., Hong, C., Kang, S., MacDougald, O. A., Goldrath, A. W. and Tontonoz, P. (2008) Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-Activated receptor-γ expression and adipocyte differentiation. Mol. Endocrinol. 22, 2038-2048.
58. Liang, C. P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I., Accili, D. and Tall, A. R. (2004) Increased CD36 protein as a response to defective insulin signaling in macrophages. J. Clin. Invest. 113, 764-773.
59. Malide, D., Davies-Hill, T. M., Levine, M. and Simpson, I. A. (1998) Distinct localization of GLUT-1, -3, and -5 in human monocyte-derived macrophages: effects of cell activation. Am. J. Physiol. 274, E516-E526.
60. Baumgartl, J., Baudler, S., Scherner, M., Babaev, V., Makowski, L., Suttles, J., McDuffie, M., Tobe, K., Kadowaki, T., Fazio, S. et al. (2006) Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE- deficient mice against atherosclerosis. Cell Metab. 3, 247-256.
61. Mauer, J., Chaurasia, B., Plum, L., Quast, T., Hampel, B., Bluher, M., Kolanus, W., Kahn, C. R. and Bruning, J. C. (2010) Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet. 6, e1000938.
62. Gong, Y., Hart, E., Shchurin, A. and Hoover-Plow, J. (2008) Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J. Clin. Invest. 118, 3012-3024.
63. Dandona, P., Ghanim, H., Bandyopadhyay, A., Korzeniewski, K., Ling Sia, C., Dhindsa, S. and Chaudhuri, A. (2010) Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care 33, 2416-2423.
64. Ghanim, H., Korzeniewski, K., Sia, C. L., Abuaysheh, S., Lohano, T., Chaudhuri, A. and Dandona, P. (2010) Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care 33, 1103-1108.
65. Dandona, P., Aljada, A., Mohanty, P., Ghanim, H., Hamouda, W., Assian, E. and Ahmad, S. (2001) Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metab. 86, 3257-3265.
66. Fan, W., Morinaga, H., Kim, J. J., Bae, E., Spann, N. J., Heinz, S., Glass, C. K. and Olefsky, J. M. (2010) FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 29, 4223-4236.
67. Han, S., Liang, C. P., DeVries-Seimon, T., Ranalletta, M., Welch, C. L., Collins-Fletcher, K., Accili, D., Tabas, I. and Tall, A. R. (2006) Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 3, 257-266.
68. Brozinick, Jr J. T., Roberts, B. R. and Dohm, G. L. (2003) Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 52, 935-941.
69. Chen, W. S., Xu, P. Z., Gottlob, K., Chen, M. L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K. et al. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208.
70. Ackah, E., Yu, J., Zoellner, S., Iwakiri, Y., Skurk, C., Shibata, R., Ouchi, N., Easton, R. M., Galasso, G., Birnbaum, M. J. et al. (2005) Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115, 2119-2127.
71. Easton, R. M., Cho, H., Roovers, K., Shineman, D. W., Mizrahi, M., Forman, M. S., Lee, V. M., Szabolcs, M., de Jong, R., Oltersdorf, T. et al. (2005) Role for Akt3/protein kinase Bγ in attainment of normal brain size. Mol. Cell. Biol. 25, 1869-1878.
72. Fernandez-Hernando, C., Ackah, E., Yu, J., Suarez, Y., Murata, T., Iwakiri, Y., Prendergast, J., Miao, R. Q., Birnbaum, M. J. and Sessa, W. C. (2007) Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 6, 446-457.
73. Ding, L., Biswas, S., Morton, R. E., Smith, J. D., Hay, N., Byzova, T. V., Febbraio, M. and Podrez, E. A. (2012) Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. Cell Metab. 15, 861-872.
74. Potente, M., Urbich, C., Sasaki, K., Hofmann, W. K., Heeschen, C., Aicher, A., Kollipara, R., DePinho, R. A., Zeiher, A. M. and Dimmeler, S. (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115, 2382-2392.
75. Tsuchiya, K., Tanaka, J., Shuiqing, Y., Welch, C. L., DePinho, R. A., Tabas, I., Tall, A. R., Goldberg, I. J. and Accili, D. (2012) FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 15, 372-381.
76. Tsuchiya, K., Westerterp, M., Murphy, A. J., Subramanian, V., Ferrante, Jr A. W., Tall, A. R. and Accili, D. (2013) Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ. Res. 112, 992-1003.
77. Kang, K., Reilly, S. M., Karabacak, V., Gangl, M. R., Fitzgerald, K., Hatano, B. and Lee, C. H. (2008) Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity. Cell Metab. 7, 485-495.
78. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z. W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J. and Karin, M. (2005) IKK-β links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198.
79. Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W. and Chawla, A. (2008) Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496-507.
80. Lee, J. Y., Sohn, K. H., Rhee, S. H. and Hwang, D. (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683-16689.
81. Westcott, D. J., Delproposto, J. B., Geletka, L. M., Wang, T., Singer, K., Saltiel, A. R. and Lumeng, C. N. (2009) MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J. Exp. Med. 206, 3143-3156.
82. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H. and Flier, J. S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025.
83. Orr, J. S., Puglisi, M. J., Ellacott, K. L., Lumeng, C. N., Wasserman, D. H. and Hasty, A. H. (2012) Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61, 2718-2727.
84. Satoh, T., Kidoya, H., Naito, H., Yamamoto, M., Takemura, N., Nakagawa, K., Yoshioka, Y., Morii, E., Takakura, N., Takeuchi, O. and Akira, S. (2013) Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature 495, 524-528.
85. Chehab, F. F. (2008) Obesity and lipodystrophy: where do the circles intersect? Endocrinology 149, 925-934.
86. Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P. et al. (2013) Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Mol. Med. 5, 441-455.
87. Newby, A. C. (2008) Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 28, 2108-2114.
88. Federici, M., Hribal, M. L., Menghini, R., Kanno, H., Marchetti, V., Porzio, O., Sunnarborg, S. W., Rizza, S., Serino, M., Cunsolo, V. et al. (2005) Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α. J. Clin. Invest. 115, 3494-3505.
89. Menghini, R., Fiorentino, L., Casagrande, V., Lauro, R. and Federici, M. (2013) The role of ADAM17 in metabolic inflammation. Atherosclerosis 228, 12-17.
90. Menghini, R., Menini, S., Amoruso, R., Fiorentino, L., Casagrande, V., Marzano, V., Tornei, F., Bertucci, P., Iacobini, C., Serino, M. et al. (2009) Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136, 663-672.
91. Cardellini, M., Menghini, R., Martelli, E., Casagrande, V., Marino, A., Rizza, S., Porzio, O., Mauriello, A., Solini, A., Ippoliti, A. et al. (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58, 2396-2401.
92. Johnson, J. L., Sala-Newby, G. B., Ismail, Y., Aguilera, C. M. and Newby, A. C. (2008) Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages. Arterioscler. Thromb. Vasc. Biol. 28, 1647-1653.
93. Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D'Alfonso, R., Gentileschi, P., Rizza, S., Marini, M. A., Porzio, O. et al. (2011) Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness. Diabetes 60, 3265-3270.
94. Casagrande, V., Menghini, R., Menini, S., Marino, A., Marchetti, V., Cavalera, M., Fabrizi, M., Hribal, M. L., Pugliese, G., Gentileschi, P. et al. (2012) Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in lowdensity lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 32, 74-81.
95. Menghini, R., Casagrande, V., Menini, S., Marino, A., Marzano, V., Hribal, M. L., Gentileschi, P., Lauro, D., Schillaci, O., Pugliese, G. et al. (2012) TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. Diabetes 61, 454-462.
96. Driscoll, W. S., Vaisar, T., Tang, J., Wilson, C. L. and Raines, E. W. (2013) Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype. Circ. Res., doi:10.1161/CIRCRESAHA.112.300683.
97. Feskens, E. J. and Kromhout, D. (1992) Glucose tolerance and the risk of cardiovascular disease: The Zutphen Study. J. Clin. Epidemiol. 45, 1327-1334.
98. Fabris, F., Zanocchi, M., Bo, M., Fonte, G., Poli, L., Bergoglio, I., Ferrario, E. and Pernigotti, L. (1994) Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke 25, 1133-1140.
99. Newman, A. B., Siscovick, D. S., Manolio, T. A., Polak, J., Fried, L. P., Borhani, N. O. and Wolfson, S. K. (1993) Ankle-Arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88, 837-845.
100. Keaney, Jr J. F. (2011) Immune modulation of atherosclerosis. Circulation 124, e559-e560.
101. Robertson, A. K. and Hansson, G. K. (2006) T cells in atherogenesis: for better or for worse? Arterioscler. Thromb. Vasc. Biol. 26, 2421-2432.
102. Krauss, S., Brand, M. D. and Buttgereit, F. (2001) Signaling takes a breath: new quantitative perspectives on bioenergetics and signal transduction. Immunity 15, 497-502.
103. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270.
104. van der Windt, G. J., Everts, B., Chang, C. H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J. and Pearce, E. L. (2012) Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68-78.